Here’s what we’re looking out for this week in the worlds of pharma and biotech:
CRISPR goes to court
On Tuesday, the warring factions in the CRISPR patent dispute will make their cases to a panel of US Patent and Trademark Office judges in Alexandria, Va. At stake are millions of dollars in licensing fees — plus bragging rights to one of the biggest discoveries in recent science history. Sharon Begley, STAT’s senior science writer, will be there.
About the Author Reprints
